Circulating tumor cells as a tool for early detection of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a significant global health concern, particularly in regions like the Asia-Pacific, where chronic viral hepatitis and liver diseases contribute to its high incidence and mortality.

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023 – Biotech Investments

Rancho Cucamonga, 02/28/2024 / 13:06, PST/PDT – EQS Newswire – Amphastar Pharmaceuticals, Inc. Reports Net Revenues of $178.1 Million for the Three Months Ended December

February 29, 2024

Novartis reports 43% increase in net income in Q2 2024

For the first half of 2024, Novartis reported net income of $5.9bn and net sales of $24.3bn. Credit: JHVEPhoto/Shutterstock. Novartis has reported a significant 43%

July 18, 2024

Electronic health record maker NextGen Healthcare to pay $31 million to resolve fraud claims

The health records company NextGen Healthcare will pay $31 million to resolve allegations that it paid kickbacks to win customers and concealed shortcomings of its

July 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.